Cardiovascular Business
Cardiovascular Business @CardioBusiness ·
Society of Vascular Surgery plays a key role in offering patients both interventional and surgical options to save their limbs. #Cardiology #PAD #CLTI #CLI ow.ly/SCI650YzW1F
Getting vascular surgeons more involved leads to key improvements for PAD patients

Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?

From cardiovascularbusiness.com
46
【公式】メディカルオンライン(Medical*Online)| 医学文献検索サイト
【公式】メディカルオンライン(Medical*Online)| 医学文献検索サイト @MedicalOnline_ ·
˗ˏˋ 大型新シリーズ公開‼ ˎˊ˗ ■━━━━━━━━━━━□ ┃3月追加の新作動画🎉 ┃ □━━━━━━━━━━━■ CLTIに対する理学療法40動画を公開🦶 発症から再発予防までを病期別に体系的に解説💡 さらに日本臨牀コラボにも3動画追加📘 臨床思考を“線”で学びませんか❓ #学療法 #CdRIr
1
4
1.1K
Abbott Cardiovascular
Abbott Cardiovascular @AbbottCardio ·
Time is critical for patients living with #CLTI – and treatment options have historically been limited. Our #EspritBTK System is helping #CLIfighters transform care for below-the-knee CLTI by improving primary patency,¹ reducing the need for repeat interventions,¹ and leaving hind.² Explore more insights @VascularOnline: bit.ly/4iTourP Safety Info: bit.ly/4iTdSJi
1
334
Pablo J. Baglioni 🇦🇷
Pablo J. Baglioni 🇦🇷 @pbaglioni ·
Replying to @pbaglioni
El papel subutilizado del IVUS 🔬 A pesar de la evidencia robusta que muestra una reducción ~50% en MALE con guía por IVUS, el estudio USM-CLTIE reporta su uso en apenas 4-9% de los procedimientos. Una oportunidad desaprovechada para mejorar resultados en #CLTI. ¡El IVUS debería ser parte del estándar de atención! #IVUS #PeripheralIntervention
1
26
Pablo J. Baglioni 🇦🇷
Pablo J. Baglioni 🇦🇷 @pbaglioni ·
Replying to @pbaglioni
🦵 La isquemia crónica que amenaza la extremidad (#CLTI) representa la forma más grave de enfermedad arterial periférica, con una mortalidad anual ~10% y alta tasa de amputación. La revascularización es el pilar del tratamiento, pero el debate sobre la mejor estrategia continúa.
1
33
Abbott Cardiovascular
Abbott Cardiovascular @AbbottCardio ·
This #IWD2026, we’re raising awareness of how CLTI affects women and calling for action across the care pathway. Women living with #CLTI often experience advanced disease and higher in-hospital complications. These disparities demand earlier recognition, better access, and options. See how our #EspritBTK System is part of our commitment to closing critical gaps in BTK care: bit.ly/3N2k2eK Safety Info: bit.ly/4s15cUO
361
Raffaele Di Giacomo, PhD
Raffaele Di Giacomo, PhD @sciqst ·
Replying to @EuroInterventio
@This is a signifi@cant findingi@n the context of #CLTI management, highlighting the potential of drug-coated devices to improve patient outcomes. It presents a compelling case for their increased use in clinical settings. I'm curious, what are your thoughts on the long-term implications of these results for surgical practice standards? For more comprehensive insights into such research, Sci-Quest is a valuable tool to explore: sciqst.com. #Medicine #Revascularisation
16